These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9238637)

  • 41. Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes VA and VB over the cytosolic and membrane-associated carbonic anhydrases I, II and IV.
    Smaine FZ; Pacchiano F; Rami M; Barragan-Montero V; Vullo D; Scozzafava A; Winum JY; Supuran CT
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6332-5. PubMed ID: 18990571
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combinatorial approaches in anticancer drug discovery: recent advances in design and synthesis.
    Bhattacharyya S
    Curr Med Chem; 2001 Oct; 8(12):1383-404. PubMed ID: 11562273
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Process technologies for purity enhancement of large discovery libraries.
    Pottorf RS; Player MR
    Curr Opin Drug Discov Devel; 2004 Nov; 7(6):777-83. PubMed ID: 15595438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening].
    Schirlin D; Galvan M; Le Fur G
    Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Target-oriented and diversity-oriented organic synthesis in drug discovery.
    Schreiber SL
    Science; 2000 Mar; 287(5460):1964-9. PubMed ID: 10720315
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combinatorial chemistry in drug research from a new vantage point.
    Maehr H
    Bioorg Med Chem; 1997 Mar; 5(3):473-91. PubMed ID: 9113325
    [No Abstract]   [Full Text] [Related]  

  • 47. Combinatorial synthesis in micro reactors.
    Watts P; Haswell SJ
    Comb Chem High Throughput Screen; 2004 Aug; 7(5):397-405. PubMed ID: 15320706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reactions in unusual media.
    Clarke D; Ali MA; Clifford AA; Parratt A; Rose P; Schwinn D; Bannwarth W; Rayner CM
    Curr Top Med Chem; 2004; 4(7):729-71. PubMed ID: 15032685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multicomponent reactions in solid-phase synthesis.
    Banfi L; Guanti G; Riva R; Basso A
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):704-14. PubMed ID: 17987522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pyrazole CCK(1) receptor antagonists. Part 2: SAR studies by solid-phase library synthesis and determination of Free-Wilson additivity.
    Sehon C; McClure K; Hack M; Morton M; Gomez L; Li L; Barrett TD; Shankley N; Breitenbucher JG
    Bioorg Med Chem Lett; 2006 Jan; 16(1):77-80. PubMed ID: 16236506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Application of efficient synthetic techniques in drug research].
    Zhou Y; Zhang L; Li Z; Liu H
    Yao Xue Xue Bao; 2013 Jul; 48(7):1014-30. PubMed ID: 24133968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Technical Advances in Medicinal Chemistry.
    Finn MG
    ACS Comb Sci; 2017 May; 19(5):277-278. PubMed ID: 28374995
    [No Abstract]   [Full Text] [Related]  

  • 53. Carbonic anhydrase inhibitors: inhibition of Plasmodium falciparum carbonic anhydrase with aromatic/heterocyclic sulfonamides-in vitro and in vivo studies.
    Krungkrai J; Krungkrai SR; Supuran CT
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5466-71. PubMed ID: 18805693
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Macrocycles: MCR synthesis and applications in drug discovery.
    Abdelraheem EMM; Shaabani S; Dömling A
    Drug Discov Today Technol; 2018 Nov; 29():11-17. PubMed ID: 30471668
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.
    Nishimori I; Minakuchi T; Kohsaki T; Onishi S; Takeuchi H; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3585-94. PubMed ID: 17482815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The importance of synthetic chemistry in the pharmaceutical industry.
    Campos KR; Coleman PJ; Alvarez JC; Dreher SD; Garbaccio RM; Terrett NK; Tillyer RD; Truppo MD; Parmee ER
    Science; 2019 Jan; 363(6424):. PubMed ID: 30655413
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diversity oriented synthesis: a challenge for synthetic chemists.
    Bender A; Fergus S; Galloway WR; Glansdorp FG; Marsden DM; Nicholson RL; Spandl RJ; Thomas GL; Wyatt EE; Glen RC; Spring DR
    Ernst Schering Res Found Workshop; 2006; (58):47-60. PubMed ID: 16708998
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biocatalysis for pharmaceutical intermediates: the future is now.
    Pollard DJ; Woodley JM
    Trends Biotechnol; 2007 Feb; 25(2):66-73. PubMed ID: 17184862
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DIVSEL and COMPLIB--strategies for the design and comparison of combinatorial libraries using pharmacophoric descriptors.
    Pickett SD; Luttmann C; Guerin V; Laoui A; James E
    J Chem Inf Comput Sci; 1998; 38(2):144-50. PubMed ID: 9538516
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advances in diversity profiling and combinatorial series design.
    Agrafiotis DK; Myslik JC; Salemme FR
    Mol Divers; 1998-1999; 4(1):1-22. PubMed ID: 10320984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.